Belfast · Northern Ireland
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works

FDA announces that it has approved the Novavax COVID-19 vaccine for youths between the ages of 12 and 17

The FDA announces that it has approved the Novavax COVID-19 vaccine for youths between the ages of 12 and 17.

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthFDA announces that it has approved the Novavax COVID-19 vaccine for youths between the ages of 12 and 17

The FDA announces that it has approved the Novavax COVID-19 vaccine for youths between the ages of 12 and 17.

View Premium plansBrowse free archive reports